✦ LIBER ✦

Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes

✍ Scribed by Nobuya Inagaki; Kohjiro Ueki; Ayuko Yamamura; Hitoshi Saito; Takeshi Imaoka

Book ID: 118103140
Publisher: Wiley (Blackwell Publishing)
Year: 2011
Tongue: English
Weight: 295 KB
Volume: 2
Category: Article
ISSN: 2040-1116
DOI: 10.1111/j.2040-1124.2011.00137.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of twice-daily exena

Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus

✍ Lu, Chieh-Hsiang; Wu, Ta-Jen; Shih, Kuang-Chung; Ni, Ewan; Reed, Victoria; Yu, M 📂 Article 📅 2013 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 307 KB

Long-term safety and efficacy of twice-d

Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD

✍ Gelb, Arthur F.; Tashkin, Donald P.; Make, Barry J.; Zhong, Xiaoyun; Garcia Gil, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 867 KB

A comparison of twice-daily exenatide an

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

✍ M. A. Nauck; S. Duran; D. Kim; D. Johns; J. Northrup; A. Festa; R. Brodows; M. T 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 196 KB

Long-term safety of linagliptin monother

Long-term safety of linagliptin monotherapy in Japanese patients with type 2 diabetes

✍ Araki, E.; Kawamori, R.; Inagaki, N.; Watada, H.; Hayashi, N.; Horie, Y.; Sarash 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Comparison of safety and tolerability wi

Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes

✍ T. Ridge; T. Moretto; L. MacConell; R. Pencek; J. Han; C. Schulteis; L. Porter 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

Efficacy and safety of glimepiride/metfo

Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes

✍ Hwang, Y.-C.; Kang, M.; Ahn, C. W.; Park, J. S.; Baik, S. H.; Chung, D. J.; Jang 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB